Because calpain-9, but not calpain-8, was decreased in gastric cancer and displayed anti-tumorigenic effects in vitro and in vivo, we next determined the correlations between calpain-9 expression and clinicopathological features in 151 gastric cancer samples. This evidence concerns the gene CAPN9 and gastric cancer.